文献速递产科母胎医学

血管生成标志物在胎儿生长受限妊娠中的预后价值

Prognostic value of angiogenic markers in pregnancy with fetal growth restriction.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-01-01

该回顾性研究纳入2013至2020年奥地利维也纳医科大学93例胎儿生长受限且疑诊子痫前期的单胎妊娠,评估sFlt-1与PlGF对子痫前期的预测价值。sFlt-1/PlGF比值预测子痫前期的能力优于单独使用sFlt-1或PlGF,<38的既定界值对排除2周内子痫前期有效,阴性预测值0.933、敏感性0.952。

要点

  • sFlt-1/PlGF比值预测子痫前期优于单独sFlt-1或PlGF。
  • sFlt-1/PlGF比值<38对排除2周内子痫前期有效,阴性预测值0.933、敏感性0.952。
  • sFlt-1/PlGF比值的风险分层能力在2周时间点后下降。

核心结论

  • 在胎儿生长受限妊娠中,使用sFlt-1/PlGF比值预测子痫前期优于单独使用PlGF。
  • 既定的sFlt-1/PlGF比值界值似乎可有效排除这些患者短期内的子痫前期发生。

研究设计与样本

  • 回顾性研究,纳入2013至2020年奥地利维也纳医科大学93例胎儿生长受限且疑诊子痫前期的单胎妊娠。
  • 胎儿生长受限按Delphi共识标准定义,采样时已确诊子痫前期的孕妇被排除。
  • 采用Cox回归和logistic回归分析血管生成标志物与不同时间点子痫前期发生的关联。

主要发现

  • 93例中,采样后1周内诊断子痫前期14例(15.1%),2周内21例(22.6%),评估后任何时间38例(40.9%)。
  • 1周内子痫前期的ROC曲线下面积:sFlt-1/PlGF比值0.87 vs sFlt-1 0.82 vs PlGF 0.72。
  • 包含sFlt-1/PlGF比值的模型与子痫前期风险关联更强:一致性指数0.790 vs 包含sFlt-1的0.759 vs 包含PlGF的0.755。
  • sFlt-1/PlGF比值<38排除2周内子痫前期:阴性预测值0.933,敏感性0.952。

关键数值与推荐

  • sFlt-1/PlGF比值<38用于排除2周内子痫前期,阴性预测值0.933、敏感性0.952。
  • 1周内子痫前期预测的ROC曲线下面积:sFlt-1/PlGF比值0.87,sFlt-1 0.82,PlGF 0.72。
  • 模型一致性指数:含sFlt-1/PlGF比值0.790,含sFlt-1 0.759,含PlGF 0.755。

临床怎么用

  • 作者认为,在胎儿生长受限妊娠中预测子痫前期,sFlt-1/PlGF比值优于单独使用PlGF。
  • 作者指出,既定的sFlt-1/PlGF比值界值似乎可有效排除这些患者短期内的子痫前期发生。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pregnancies with fetal growth restriction (FGR) are at increased risk for pre-eclampsia. Angiogenic markers including soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) are altered in pregnancies complicated by FGR, but their utility for predicting pre-eclampsia in growth-restricted pregnancies is uncertain. This study aimed to evaluate the prognostic value of angiogenic markers for predicting the development of pre-eclampsia in pregnancies with FGR and suspected pre-eclampsia. METHODS: This was a retrospective study of singleton pregnancies with FGR, defined according to Delphi consensus criteria, which underwent sampling of sFlt-1 and PlGF for suspicion of pre-eclampsia at the Medical University of Vienna, Vienna, Austria, between 2013 and 2020. Women with an established diagnosis of pre-eclampsia at sampling were excluded. Cox regression analysis and logistic regression analysis were performed to evaluate the association of angiogenic markers with the development of pre-eclampsia at various timepoints. RESULTS: In this cohort of 93 women, pre-eclampsia was diagnosed in 14 (15.1%) women within 1 week after sampling, 21 (22.6%) within 2 weeks after sampling and 38 (40.9%) at any time after assessment. The sFlt-1/PlGF ratio consistently showed a stronger association with the development of pre-eclampsia compared to sFlt-1 or PlGF alone (pre-eclampsia within 1 week: area under the receiver-operating-characteristics curve, 0.87 vs 0.82 vs 0.72). Models including the sFlt-1/PlGF ratio were associated more strongly with pre-eclampsia hazard compared to models including sFlt-1 or PlGF alone (concordance index, 0.790 vs 0.759 vs 0.755). The risk classification capability of the sFlt-1/PlGF ratio decreased after the 2-week timepoint. The established cut-off value for the sFlt-1/PlGF ratio of < 38 was effective for ruling out pre-eclampsia within 2 weeks, with a negative predictive value of 0.933 and sensitivity of 0.952. CONCLUSIONS: Use of the sFlt-1/PlGF ratio is preferrable to the use of PlGF alone for the prediction of pre-eclampsia in pregnancies with FGR. Established cut-offs for ruling out the development of pre-eclampsia in the short term seem to be effective in these patients. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Palmrich P, Kalafat E, Pateisky P, et al. Prognostic value of angiogenic markers in pregnancy with fetal growth restriction. Ultrasound Obstet Gynecol. 2024. PMID: 37774098. doi:10.1002/uog.27509

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。